Screener
Xenon Pharmaceuticals XENE Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
FAQ
- What is Xenon Pharmaceuticals's asset turnover?
- Xenon Pharmaceuticals (XENE) reported asset turnover of 0× in Q2 2026.
- How has Xenon Pharmaceuticals's asset turnover changed year-over-year?
- Xenon Pharmaceuticals's asset turnover decreased by 100.0% year-over-year, from 0× to 0×.
- What is the long-term trend for Xenon Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's asset turnover has grown at a -44.0% compound annual growth rate (CAGR), from 0.2× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Xenon Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude